Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

Histopathology

Volumn 32, Issue 2, 1998, Pages 133-138

  Terris, B ^a   Scoazec, J Y ^b   Rubbia, L ^a   Bregeaud, L ^a   Pepper, M S ^c   Ruszniewski, P ^a   Belghiti, J ^a   Flejou J F ^a   Degott, C ^a  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Carcinoid; Neuroendocrine; Tumours; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; HUMAN; HUMAN TISSUE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BLOOD FLOW; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA, ISLET CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; GASTRINOMA; GASTROINTESTINAL NEOPLASMS; GLUCAGONOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULINOMA; LYMPHOKINES; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031906775     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00321.x     Document Type: Article

References (36)

1. Folkman J, Shiny Y. Angiogenesis. J. Biol. Chem. 1992: 267; 10931-10934.
2. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 1991: 324; 1-8.
3. Yamazaki K, Abe S, Takekawa H et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994: 74; 2245-2250.
4. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo-stellate cells. Proc. Natl. Acad. Sci. (USA) 1989: 86; 7311-7315.
5. Ferrara N, Henzel WJ. Pituitary follicular secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989: 161; 851-858.
6. Fox SB, Gatter KC, Harris AL. Tumour angiogenesis. J. Pathol. 1996: 179; 232-237.
7. Senger DR. Molecular framework for angiogenesis. A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am. J. Pathol. 1996: 149; 1-7.
8. Brown LF, Berse B, Jackman RW et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor. Hum. Pathol. 1995: 26; 86-91.
9. Mattern J, Koomägi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 1996: 73; 931-934.
10. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997: 79; 206-213.
11. Mise M, Arii S, Higashitudji H et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996: 23; 455-464.
12. Christofori G, Naik P, Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endo. 1995: 9; 1760-1770.
13. Kuroda M, Oka T, Oka Y et al. Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J. Clin. Endocrinol. Metab. 1995: 80; 3196-3200.
14. Rooman I, Schuit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation on pancreatic ductal epithelium. Lab. Invest. 1997: 76; 225-232.
15. Harper ME, Glynne-Jones E, Goddard L, Thurston VJ, Griffith K. Vaascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. Br. J. Cancer 1996: 74; 910-916.
16. Terris B, Fléjou JF, Dubois S et al. Increased expression of CD44v6 in endocrine pancreatic tumors but not in midgut carcinoid tumors. J. Clin. Pathol. Mol. Pathol. 1996: 49; M203-M208.
17. Scoazec J-Y, Delautier D, Moreau A et al. Expression of complement regulatory proteins in normal and UW-preserved human liver tissue: possible relevance to liver transplantation. Gastroenterology 1994: 107; 505-516.
18. Scoazec J-Y, Maurice M, Moreau A, Feldmann G. Analysis of hepatocyte plasma membrane polarity during rat azo-dye hepatocarcinogenesis using monoclonal antibodies directed against domain-associated antigens. Cancer Res. 1988: 48; 6882-6890.
19. Senger DR, Van De Water L, Brown LF et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993: 12; 303-324.
20. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab. 1996: 81; 353-359.
21. Brown LF, Berse B, Tognazzi K et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Internat. 1992: 42; 1457-1461.
22. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 1997: 57; 765-772.
23. Abu-Jawdeh G, Faix JD, Niloff J et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Invest. 1996: 74; 1105-1115.
24. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992: 359; 843-845.
25. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992: 359; 845-848.
26. Brown LF, Berse B, Jackman RW et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 1993: 53; 4727-4735.
27. Beauchamp D, Coffey RJ, Lyons RM, Perkett EA, Townsend CM, Moses HL. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth. Cancer Res. 1991: 51; 5253-5260.
28. Nilsson O, Wängberg B, Theodorsson E, Skottner A, Ahlman H. Presence of IGF-I in human carcinoid tumours - an autocrine regulator of carcinoid tumour growth? Int. J. Cancer 1992: 51; 195-203.
29. Driman DK, Kobrin MS, Kudlow JE, Asa SL. Transforming growth factor-α in normal and neoplastic human endocrine tissues. Human Pathol. 1992: 23; 1360-1365.
30. Nilsson O, Wängberg B, Kölby L, Schultz G, Ahlman H. Expression of transforming growth factor alpha and its receptor in human endocrine tumours. Int. J. Cancer 1995: 60; 645-651.
31. Chaudhry A, Papanicolaou V, Oberg K, Heldin CH, Funa K. Expression of platelet derived growth factor and its receptor in neuroendocrine tumors of the digestive system. Cancer Res. 1992: 52; 1006-1012.
32. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 1992: 189; 824-831.
33. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am. J. Surg. Pathol 1995: 19; 642-652.
34. Takano S, Yoshii Y, Kondo S et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 1996: 56; 2185-2190.
35. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H. Vascular growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochem. Biophys. Acta 1994: 1221; 211-214.
36. Heits F, Katschinski DM, Wiedemann GJ, Weiss C, Jelkmann W. Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. Int. J. Oncol. 1997: 10; 333-337.